JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 18, 2007; DOI: 10.1124/jpet.107.130336


0022-3565/08/3241-103-110$20.00
JPET 324:103-110, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.130336v1
324/1/103    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishizuka, T.
Right arrow Articles by Laniado-Schwartzman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishizuka, T.
Right arrow Articles by Laniado-Schwartzman, M.

CELLULAR AND MOLECULAR

20-Hydroxyeicosatetraenoic Acid Stimulates Nuclear Factor-{kappa}B Activation and the Production of Inflammatory Cytokines in Human Endothelial Cells

Tsuneo Ishizuka, Jennifer Cheng, Harpreet Singh, Marco D. Vitto, Vijay L. Manthati, John R. Falck, and Michal Laniado-Schwartzman

Department of Pharmacology, New York Medical College, Valhalla, New York (T.I., J.C., H.S., M.D.V., M.L.-S.); and Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas (V.L.M., J.R.F.)

Endothelial dysfunction is associated with endothelial cell activation, i.e., up-regulation of surface cell adhesion molecules and the release of proinflammatory cytokines. 20-Hydroxyeicosatetraenoic acid (HETE), a major vasoactive eicosanoid in the microcirculation, has been implicated in the regulation of endothelial cell function through its angiogenic and pro-oxidative properties. We examined the effects of 20-HETE on endothelial cell activation in vitro. Cells transduced with adenovirus containing either CYP4A1 or CYP4A2 produced higher levels of 20-HETE, and they demonstrated increased expression levels of the adhesion molecule intercellular adhesion molecule (ICAM) (4–7-fold) and the oxidative stress marker 3-nitrotyrosine (2–3-fold) compared with cells transduced with control adenovirus. Treatment of cells with 20-HETE markedly increased levels of prostaglandin (PG) E2 and 8-epi-isoprostane PGF2{alpha}, commonly used markers of activation and oxidative stress, and most prominently, interleukin-8, a potent neutrophil chemotactic factor whose overproduction by the endothelium is a key feature of vascular injury. 20-HETE at nanomolar concentrations increased inhibitor of nuclear factor-{kappa}B phosphorylation by 2 to 5-fold within 5 min, which was followed with increased nuclear translocation of nuclear factor-{kappa}B (NF-{kappa}B). Likewise, 20-HETE activated the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway by stimulating phosphorylation of ERK1/2. Inhibition of NF-{kappa}B activation and inhibition of ERK1/2 phosphorylation inhibited 20-HETE-induced ICAM expression. It seems that 20-HETE triggers NF-{kappa}B and MAPK/ERK activation and that both signaling pathways participate in the cellular mechanisms by which 20-HETE activates vascular endothelial cells.


Received August 31, 2007; accepted October 17, 2007.

Address correspondence to: Dr. Michal Laniado-Schwartzman, Department of Pharmacology, New York Medical College, 15 Dana Rd., Valhalla, NY 10595. E-mail: michal_schwartzman{at}nymc.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Dhanasekaran, S. Bodiga, S. Gruenloh, Y. Gao, L. Dunn, J. R. Falck, J. N. Buonaccorsi, M. Medhora, and E. R. Jacobs
20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H777 - H786.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.